Terms: = Head and neck cancer AND CEACAM5, CEA
943 results:
1. Initial presentation of hepatocellular carcinoma as pharyngeal mass mimicking advanced hypopharyngeal carcinoma.
Sukumaran R; Kattoor J; Valsalamony J; Varghese BT
J Cancer Res Ther; 2024 Jan; 20(1):438-440. PubMed ID: 38554358
[TBL] [Abstract] [Full Text] [Related]
2. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
[No Abstract] [Full Text] [Related]
3. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
Perrier L; Balusson F; Morelle M; Castelli J; Thariat J; Benezery K; Hasbini A; Gery B; Berger A; Liem X; Guihard S; Chapet S; Thureau S; Auberdiac P; Pommier P; Ruffier A; Devillers A; Oger E; Campillo-Gimenez B; de Crevoisier R
Radiother Oncol; 2024 Apr; 193():110116. PubMed ID: 38316193
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery.
Hamai Y; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Kurokawa T; Yoshikawa T; Hirohata R; Ohsawa M; Kitasaki N; Okada M
World J Surg; 2024 Feb; 48(2):416-426. PubMed ID: 38310312
[TBL] [Abstract] [Full Text] [Related]
6. An audit of medullary thyroid carcinoma from a tertiary care hospital in northwest India.
Chakraborty AM; Rai A; Pal R; Mukherjee S; Dahiya D; Kumar R; Saikia UN; Panda NK; Bhadada SK; Dutta P
Front Endocrinol (Lausanne); 2023; 14():1226348. PubMed ID: 38260132
[TBL] [Abstract] [Full Text] [Related]
7. A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers.
Dai Y; Li H; Wu Q; Wang J; Wang K; Fei S; Pei B; Song L; Chen G; Ma Y; Xia C; Xiong S; Zheng M; Xue Y; Zhao G; Xu H
Neoplasia; 2023 Dec; 46():100941. PubMed ID: 37918207
[TBL] [Abstract] [Full Text] [Related]
8. Carotid endarterectomy for the management of carotid stenosis occurring concurrently with head and neck cancer.
Telischi J; Nisenbaum E; Nicolli E
Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):452-456. PubMed ID: 37916904
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of pretreatment FDG PET-CT for short-term efficacy of radioactive iodine-125 seed implantation in patients with NSCLC.
Hu T; Shen J; Shao M; Feng X; Lu D; Ding E
Brachytherapy; 2023; 22(6):882-888. PubMed ID: 37758577
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
Miao Q; Lv X; Luo L; Zhang J; Cai B
Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
[TBL] [Abstract] [Full Text] [Related]
13. Effect of neoadjuvant therapy on serum transforming growth factor-β, squamous cell carcinoma associated antigen, and prognosis in patients with locally advanced esophageal cancer.
Zhang R; Tian W; Zhao H; Zhang Z; Wu J; Sun S; Liu H
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):112-118. PubMed ID: 37571892
[TBL] [Abstract] [Full Text] [Related]
14. First-line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta-analysis and cost-effectiveness analysis.
Han J; Zeng N; Tian K; Liu Z; She L; Wang Z; He J; Chen N
Head Neck; 2023 Sep; 45(9):2246-2258. PubMed ID: 37435624
[TBL] [Abstract] [Full Text] [Related]
15. Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer.
Matsui K; Kawakubo H; Matsuda S; Hirata Y; Irino T; Fukuda K; Nakamura R; Okita H; Kitagawa Y
Esophagus; 2023 Oct; 20(4):679-690. PubMed ID: 37222963
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of safety and efficacy of autologous oral mucosa-derived epithelial cell sheet transplantation for prevention of anastomotic restenosis in congenital esophageal atresia and congenital esophageal stenosis.
Fujino A; Fuchimoto Y; Mori T; Kano M; Yamada Y; Ohno M; Baba Y; Isogawa N; Arai K; Yoshioka T; Abe M; Kanai N; Takagi R; Maeda M; Umezawa A
Stem Cell Res Ther; 2023 Apr; 14(1):86. PubMed ID: 37055850
[TBL] [Abstract] [Full Text] [Related]
17. Factors affecting the ORR after neoadjuvant therapy of TP regimen combined with PD-1 inhibitors for esophageal cancer.
Ma R; Yuan D; Mo C; Zhu K; Dang C; Zhang Y; Yin J; Li K
Sci Rep; 2023 Apr; 13(1):6080. PubMed ID: 37055490
[TBL] [Abstract] [Full Text] [Related]
18. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
Yin L; Chen GL; Xiang Z; Liu YL; Li XY; Bi JW; Wang Q
Biomed Pharmacother; 2023 Jun; 162():114648. PubMed ID: 37023621
[TBL] [Abstract] [Full Text] [Related]
19. [Value of Baseline Calcitonin for Differential Diagnosis of Medullary Thyroid cancer].
Liu QH; Nie X; He Y; Yin MT; Li GX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):432-438. PubMed ID: 36949711
[TBL] [Abstract] [Full Text] [Related]
20. Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: A systematic review and meta-analysis.
Nurczyk K; Nowak N; Carlson R; Skoczylas T; Wallner G
Adv Med Sci; 2023 Mar; 68(1):138-146. PubMed ID: 36944288
[TBL] [Abstract] [Full Text] [Related]
[Next]
